Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 8, 1998, Pages 811-817

  Ishii, Ritsuko ^a   Furuta, Motoko ^a   Hashimoto, Masayo ^a   Tagawa, Takeshi ^a   Naruse, Tomohiro ^a   Hata, Taeko ^b  

^a Maruho Co   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Antihypertensive drugs; CAS 4205 90 7; Clonidine, spontaneously hypertensive rats, transdermal delivey system; Norepinephrine, in plasma and urine

Indexed keywords

CLONIDINE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORADRENALIN URINE LEVEL; ORAL DRUG ADMINISTRATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; ANIMALS; CLONIDINE; HYPERTENSION; MALE; NOREPINEPHRINE; RATS; RATS, INBRED SHR; URODYNAMICS;

EID: 0031826127     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Timmermans, P. B. M. W. M., in: Handbook of hypertension, P. A. van Zwieten (ed.), Vol. 3, pp. 102-153, Elsevier Science Publishers, Amsterdam (1984)
2. Brown, M. J., Harland, D., Br. J. Pharmacol. 83, 657 (1984)
3. Conway, E. L., Brown, M. J., Dollery, C. T., J. Pharmacol. Exp. Ther. 229, 803 (1984)
4. Keeton, T. K., Biediger, A. M., Naunyn-Schmiedeberg's Arch. Pharmacol. 338, 350 (1988)
5. Koenig-Berard, E., Tierney, C., Beau, B. et al., Am. J. Cardiol. 61, 22D (1988)
6. Chang, A. P. L., Dillard, M., Dixon, W. R., J. Cardiovasc. Pharmacol. 13, 277 (1989)
7. El-Mas, M. M., Carroll, R. G., Abdel-Rahman, A. A., J. Cardiovasc. Pharmacol. 24, 184 (1994)
8. Hökfelt, B., Hedeland, H., Dymling, J. F., Eur. J. Pharmacol. 10, 389 (1970)
9. Hökfelt, B., Hedeland, H., Hansson, B. G., Arch. Int. Pharmacodyn. 213, 307 (1975)
10. Wing, L. M. H., Reid, J. L., Hamilton, C. A. et al., Clin. Sci. Mol. Med. 53, 45 (1977)
11. Hansson, B. G., Hökfelt, B., Br. J. Clin. Pharmacol. 1, 73 (1981)
12. Arndts, D., Doevendans, J., Kirsten, R. et al., Eur. J. Clin. Pharmacol. 24, 21 (1983)
13. Goldstein, D. S., Levinson, P. D., Zimlichman, R. et al., Ann. Intern. Med. 102, 42 (1985)
14. Davies, D. S., Wing, L. M. H., Reid, J. L., et al., Clin. Pharmacol. Ther. 21, 593 (1977)
15. Lowenthal, D. T., J. Cardiovasc. Pharmacol. 2 (Suppl. 1), S 29 (1980)
16. Weber, M. A., Drayer, J. I. M., Brewer, D. D., Lipson, J. L., Lancet 1, 9 (1984)
17. Langley, M. S., Heel, R. C., Drugs 35, 123 (1988)
18. Lowenthal, D. T., Matzek, K. M., MacGregor, T. R., Clin. Pharmacokinet. 14, 287 (1988)
19. Groth, H., Vetter, H., Knüsel, J. et al., 62, 925 (1984)
20. Maibach, H., Contact Dermatitis 12, 192 (1985)
21. Hayakawa, R., Matsunaga, K., Suzuki, M. et al., Skin. Res. 33, 356 (1991) (Abstract in English)
22. Ishii, R., Naruse, T., Tagawa, T. et al., Arch. Int. Pharmacodyn. 327, 294 (1994)
23. Ishii, R., Tagawa, T., Ishida, T. et al., Arzneim.-Forsch./Drug Res. 46 (I), 261 (1996)
24. Naruse, T., Ishida, T., Ishii, R. et al., Fundam. Clin. Pharmacol. 10, 47 (1996)
25. Weicker, H., Feraudi, M., Hägele, H. et al., Clinica Chimica Acta 141, 17 (1984)
26. Dimson, P. A., Current 3, 4 (1984)
27. Goldstein, D. S., McCarty, R., Polinsky, R. J. et al., Hypertension 5, 552 (1983)
28. Kopin, I. J., in: Handbook of experimental pharmacology. U. Trendelenburg, N. Weiner (eds.), Vol. 90/II, pp. 211-275, Springer-Verlag, Berlin (1989)
29. Roman, R. J., Cowley, A. W. Jr., Lechene, C., J. Pharmacol. Exp. Ther. 211, 385 (1979)
30. Miller, M., J. Pharmacol. Exp. Ther. 214, 608 (1980)
31. Kauker, M. L., Barr, J. G., Arch. Int. Pharmacodyn. 249, 106 (1981)
32. Blandford, D. E., Smyth, D. D., J. Pharmacol. Exp. Ther. 247, 1181 (1988)
33. Pan, L., Gutkowska, J., Endocrinology 123, 1259 (1988)
34. Patel, K. P., Zeigler, D. W., Proc. Soc. Exp. Biol. Med. 202, 81 (1993)